NIOX GROUP PLC Logo

NIOX GROUP PLC

NIOX | IL

Overview

Corporate Details

ISIN(s):
GB00BJVD3B28 (+1 more)
LEI:
2138006YAT138TOGA556
Country:
United Kingdom
Address:
HAYAKAWA BUILDING EDMUND HALLEY ROAD, OX4 4GB OXFORD
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

NIOX Group PLC is a medical technology company specializing in the design, development, and commercialization of devices for respiratory disease management. The company's core focus is on the non-invasive measurement of fractional exhaled nitric oxide (FeNO), a key biomarker for airway inflammation. Its market-leading 'FeNO by NIOX®' product range, including the NIOX VERO® point-of-care device, is used globally by physicians and clinical researchers to aid in the diagnosis, monitoring, and management of chronic airway diseases, primarily asthma. The technology is established as a standard for FeNO testing, supporting clinical decision-making in both primary and secondary care environments.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for NIOX GROUP PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 13:21
Major Shareholding Notification
Holding(s) in Company
English 54.1 KB
2025-08-06 11:35
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-08-01 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 8.0 KB
2025-07-22 14:48
Director's Dealing
PDMR/PCA Shareholding
English 21.9 KB
2025-06-25 16:45
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-06-25 11:30
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-06-17 12:45
Major Shareholding Notification
Holding(s) in Company
English 69.3 KB
2025-06-02 08:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 8.0 KB
2025-05-28 14:19
Major Shareholding Notification
Holding(s) in Company
English 23.9 KB
2025-05-27 11:00
Regulatory News Service
Change of Adviser
English 8.7 KB
2025-05-23 11:22
Major Shareholding Notification
Holding(s) in Company
English 25.7 KB
2025-05-14 16:00
Post-Annual General Meeting Information
Result of Annual General Meeting
English 8.9 KB
2025-05-14 08:00
Pre-Annual General Meeting Information
AGM Statement
English 12.2 KB
2025-04-24 11:49
Notice of Dividend Amount
Dividend Declaration
English 8.9 KB
2025-03-26 15:22
Major Shareholding Notification
Form 8.3 - NIOX Group PLC - Amendment
English 65.6 KB

Automate Your Workflow. Get a real-time feed of all NIOX GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NIOX GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN